Pharma BD Deal Intelligence
Cephalon, Inc. / Cell Therapeutics, Inc.
2005 · Asset Purchase · $70M · Complete
Announcement Sentiment
80
Strongly positive
Cephalon acquires worldwide rights (ex-Asia) to TRISENOX (arsenic trioxide) from Cell Therapeutics. Oncology asset deal.
Key facts
- Announced Jun 13, 2005
- Closed Jul 18, 2005
- Deal value $70M
- Deal type Asset Purchase
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals